Zurita, A J
Khajavi, M
Wu, H-K
Tye, L
Huang, X
Kulke, M H
Lenz, H-J
Meropol, N J
Carley, W
DePrimo, S E
Lin, E
Wang, X
Harmon, C S
Heymach, J V
Article History
Revised: 23 December 2014
Accepted: 29 January 2015
First Online: 10 March 2015
Competing interests
: Employment or leadership position: LT and XH, Pfizer; WC, MindPiece Partners, prior employee of Pfizer; SEDP, prior employee of Pfizer. Consultant or advisory role: MHK, Novartis, Pfizer, Lexicon; CSH, Pfizer (was an employee of Atrium Staffing (New York, NY, USA) and a paid contractor of Pfizer during the development of this manuscript and the analysis and interpretation of the data); JVH, Pfizer. Stock ownership: LT, XH, WC, Pfizer; Charles S. Harmon, Pfizer (family member). Honoraria: JVH, Pfizer. Research funding: AJZ, WC and JVH, Pfizer; MHK, Novartis. Expert testimony: MHK, Pfizer. Other remuneration: None. MK, H-KW, H-JL, NJM, EL, and XW declare no conflicts of interest.